
Sign up to save your podcasts
Or


In a podcast conversation with Pharm Exec, Ken Banta, founder and CEO of The Vanguard Network, and Andrew Hall, CEO of Consano Bio, discuss what effective leadership looks like in today’s volatile capital and regulatory climates for emerging biotechs. Part 1 of the conversation explores why Banta and Hall believe CEOs of these companies must act as stabilizers and translators—balancing risk with opportunity and turning complex scientific innovation into clear strategy for investors, regulators, and employees alike.
Highlights of the discussion include:
By Pharmaceutical Executive Podcast4.9
1414 ratings
In a podcast conversation with Pharm Exec, Ken Banta, founder and CEO of The Vanguard Network, and Andrew Hall, CEO of Consano Bio, discuss what effective leadership looks like in today’s volatile capital and regulatory climates for emerging biotechs. Part 1 of the conversation explores why Banta and Hall believe CEOs of these companies must act as stabilizers and translators—balancing risk with opportunity and turning complex scientific innovation into clear strategy for investors, regulators, and employees alike.
Highlights of the discussion include:

30,609 Listeners

4,225 Listeners

3,228 Listeners

1,713 Listeners

4,420 Listeners

427 Listeners

1,649 Listeners

154 Listeners

1,448 Listeners

9,556 Listeners

337 Listeners

1,320 Listeners

6,097 Listeners

87 Listeners

150 Listeners